Publicaciones en las que colabora con Fermín Sánchez-Guijo Martín (24)
2024
-
Autonomic dysfunction as manifestation of ICANS: A case report
Medicine (United States), Vol. 103, Núm. 36, pp. e38659
-
Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients
Blood cancer journal
-
Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells
Cytotherapy, Vol. 26, Núm. 8, pp. 806-812
2022
-
CT-169 Cytokine Release Syndrome After Peripheral Blood Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide: Time of Onset Matters
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S437-S438
-
CT-195 Predictive Value of ST2, REG3a, and MAGIC Algorithm in Haploidentical Transplantation With Post-Transplant Cyclophosphamide Outcomes
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S438
2020
-
Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 Pandemic
Frontiers in Medicine, Vol. 7
2019
-
Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation
Bone Marrow Transplantation
-
Vitamin D modifies the incidence of graft-versus-host disease after allogeneic stem cell transplantation depending on the Vitamin D Receptor (VDR) polymorphisms
Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4616-4623
2016
-
GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: Results of a multicenter study
Bone Marrow Transplantation
-
Immunomodulatory effect of Vitamin D after allogeneic stem cell transplantation: Results of a prospective multicenter clinical trial
Clinical Cancer Research, Vol. 22, Núm. 23, pp. 5673-5681
2015
-
Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant
British Journal of Haematology, Vol. 169, Núm. 5, pp. 719-725
-
Influence of donor age in allogeneic stem cell transplant outcome in acute myeloid leukemia and myelodisplastic syndrome
Leukemia Research, Vol. 39, Núm. 8, pp. 828-834
2014
-
Late differentiation syndrome in acute promyelocytic leukemia: A challenging diagnosis
Hematology Reports, Vol. 6, Núm. 4, pp. 75-77
-
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus
Bone Marrow Transplantation, Vol. 49, Núm. 5, pp. 684-690
-
Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndrome
Leukemia Research, Vol. 38, Núm. 5, pp. 551-556
-
Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation, Vol. 20, Núm. 10, pp. 1580-1585
2013
-
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients
Haematologica, Vol. 98, Núm. 3, pp. 437-443
2012
-
Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation
Transfusion, Vol. 52, Núm. 5, pp. 1086-1091
2011
-
Effect of vitamin D treatment in chronic GVHD
Bone Marrow Transplantation
2010
-
Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant
American Journal of Hematology, Vol. 85, Núm. 4, pp. 290-293